Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2-MedSci.cn

Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2

Sehn, L; Chamuleau, M; Lenz, G; Clausen, M; Haioun, C; Izutsu, K; Davies, A; Zhu, J; Oki, T; Szafer-Glusman, E; Conlon, R; Chiou, HY; Ipe, D; Elliott, B; Wu, J; Salles, G

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023; 23 (): S440

科室
- - 订阅+
  - 更多科室
工具
服务